Skip to main content
Download PDF
  • Research article
  • Open access
  • Published:

Effect of Streptococcus anginosus on biological response of tongue squamous cell carcinoma cells

BMC Oral Health volume 21, Article number: 141 (2021) Cite this article

Abstract

Background

Streptococcus anginosus (S. anginosus) was reported increased in oral squamous cell carcinoma (OSCC) tissue. The aim of this study was to investigate the response of oral cancer cells in the biological characteristics evoked by the S. anginosus and investigate its potential mechanisms.

Methods

The growth curve and concentration standard curve of S. anginosus were determined, and a series of concentrations of S. anginosus supernatant were applied to OSCC cell lines SCC15, then selected an optimal time and concentration by CCK-8 assay. Then autophagic response, proliferative activity, cell cycle and apoptosis, invasion and migration abilities were evaluated in SCC15.

Results

The results showed that when the ratio of S. anginosus supernatant to cell culture medium was 1:1 and the co-culture time was 16 h, the inhibitory effect on SCC15 was the most obvious; Furthermore, the supernatant of Streptococcus upregulated the autophagy activity of SCC15, thus significantly inhibiting its proliferation, migration and invasion ability. Compared with control groups, the cell cycle showed G1 arrest, S and G2/M phases decreased, and the percentage of apoptotic cells relatively increased (P < 0.05).

Conclusion

S. anginosus reduced the proliferation, migration and invasion of SCC15 cells and promoted cell apoptosis; Moreover, autophagy may be one of the mechanisms in this process.

Peer Review reports

Background

In the 1990s, the researchers found that there may be a relationship existed between microbes and tumors [1]. Studies have showed that the primary cause of carcinogenesis was the changes in cellular metabolism [2]. Microorganisms participate in a series of metabolic activities of the host, and the metabolites or co-metabolites (produced by the interaction between the host and the microorganisms) of microorganisms will affect the proliferation and apoptosis of tissue cells and the growth and metastasis of cells in the tumor microenvironment [3, 4]. Currently, the application status of microorganisms in cancer treatment includes: as a natural medicine database, bacteria provide various active substances with anti-tumor properties; As a delivery vehicle, bacteria specifically target drugs to tumor cells; As a therapeutic agent, bacteria combining with chemoradiotherapy and immunotherapy synergistically promote the efficacy of traditional anti-tumor therapy [5].

The human digestive flora is the second set of human genomes, which inhabits a large number of microorganisms, and the number of which is 10 times the number of their own cells. The micro-ecological system composed of these bacteria maintains the stability and balance of the microbial community under their interaction. In recent years, with the development of technologies like metagenomics and high-throughput sequencing, research on microbes and human health and diseases has gradually started. More and more studies have found that in some digestive tract tumors, the composition of the flora has changed significantly, and some bacteria have increased or decreased in specificity. Helicobacter pylori has been identified as an independent risk factor for gastric cancer, while studies have also reported that beneficial bacteria such as bifidobacteria can inhibit the occurrence and development in gastric tumors. Therefore, scholars have proposed that microbes could be regarded as a double-edged sword in tumors. The metabolism of cancer cells will become a promising therapeutic target, and the role of microorganisms in cancer treatment is becoming more and more important [6].

The oral cavity is not only the initiation site of digestive tract but also the predilection site of head and neck malignant tumors, and 90% of oral cancers are squamous cell carcinoma. Studies have found that patients with oral squamous cell carcinoma (OSCC) have some significant changes in the microbial diversity of cancer tissues and saliva compared with healthy people, such as Streptococcus, Porphyromonas, fusobacterium, Veillonella, Actinomyces, Enterobacter and so on [7,8,9]. S. anginosus is a commensal bacterium in the oral cavity, gastrointestinal tract and genitourinary tract. Previous studies have shown that the detection rate of this strain in esophageal cancer and oral squamous cell carcinoma is significantly increased and the pathogenicity in esophageal cancer has been clear [10,11,12]. The oral cavity connects with esophagus, some researchers considered that this kind of bacterium may involve in oral squamous cell carcinoma [13, 14]. A previous study on the cancer tissues of different sites in oral cavity estimated that the total detection rate of S. anginosus DNA was as high as 88%, and each part was 87% of tongue, 90% of mouth, 83% of cheek, 100% of gums, and this rate was found much less frequently in healthy people [15].

In this study, we estimated the changes of SCC15 cells fate by S. anginosus and explored the potential mechanism that reveal the impact of this bacterium on the biological characteristics of oral cancer cells.

Methods

Baterial growth curve and concentration standard curve

S. anginosus strain ATCC33397 (supported by the State Key Laboratory of Oral Disease, Sichuan University) was cultured aerobically at 37 °C in THB medium (Solarbio, China) and measure the absorbance every 2 h. Then the relationship between concentration of bacteria solution and absorbance value was obtained by serial dilution plate counting method.

Cell culture

The oral tongue squamous cell carcinoma cells SCC15 (supported by Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences) were cultured in DMEM/F12 with 10% fetal bovine serum (Gibco, USA) containing 100U/ml penicillin and 100 μg/ml streptomycin at 37 °C and 5% CO2.

Co-culture time and concentration

The S. anginosus supernatant in stable phases was used for the experiment, treating with centrifugation at 4000 rpm/min for 20 min and filtering twice with 0.22 μm filters. Then, the treated supernatant was called filtrate S and the bacterial medium THB was treated in the same manner as a control, called filtrate T. The Subsequent experiments were carried out with filtrate S and filtrate T. A series of concentrations of filtrate S were applied to SCC15, then an optimal co-culture time and concentration were obtained by CCK-8 assay.

Experimental groups and manipulating approaches

Methods to set up SCC15/ S. anginosus (SCC15/S) experimental group, SCC15/THB (SCC15/T) conditional control group, SCC15/S+3-MA conditional control group, SCC15/3-MA negative control group and SCC15 blank control group. Meanwhile, SCC15 group did not do any treatment, while SCC15/S, SCC15/T and SCC15/3-MA acted with filtrate S, filtrate T and 3-Methyladenine (3-MA) for 16 h respectively; SCC15/S+3-MA pretreated with 3-MA for 4 h and then infected with filtrate S for 16 h.

Autophagic response measurement

Monodansylcadaverine staining

Monodansylcadaverine (MDC) staining was an independent method to evaluate autophagy. SCC15 cells were seeded in confocal dishes. After each group was treated accordingly,10 μL MDC stain was added and mixed, and incubated at 37 °C for 20 min away from light; Then washed with 300μL 1X wash buffer twice. Pictures were obtained with the confocal microscope (Thermo, USA).

Real time PCR analysis

Total RNA was isolated from SCC15 cells using Trizol method (Beyotime, China). cDNA was synthesized by qScript cDNA synthesis kit (Sigma, USA) and primers synthesized by Wuhan Sevier Biotechnology Co., Ltd. The sequences are shown in Table 1. Quantitative gene expression was performed for Beclin1, LC3 using one-step RT-PCR kit (Takara, Japan). Expression values were normalized to GAPDH.

Table 1 Primers used in RT‐PCR analysis
Full size table

Western blot analysis

The cell samples were collected and lysed in RIPA with PMSF (Beyotime, China). Then, protein concentration was mearsured by BCA protein kit (Beyotime, China). The cell lysates were separated by 10% SDS–PAGE and transferred to the 0.22 μm PVDF membranes. The bands were detected by enhanced chemiluminescence (ECL) after the primary antibody at 4 °C for a night and second antibody at room temperature for 1 h. The antibodies used in this study include: anti-LC3, anti-Beclin1 (Cell Signaling, USA) and GAPDH (Beyotime, China).

Cell proliferation analysis

Cells were seeded in a 96-well plate at a density of 5 × 103/well and incubated at 37 °C for 24 h, then each group was treated accordingly. After that,10 μL CCK-8/well with 100 μL DMEM/F12 was added and incubated at 37 °C for 4 h. Absorbance was determined at 450 nm with a microplate reader.

Cell cycle and apoptosis analysis

The cells were digested with trypsin and washed with cold PBS, then fixed overnight in 70% ethanol at − 4 °C. Ethanol-fixed cells were collected and washed with PBS, then cell counting. 106cells of each group were centrifuged and 0.5 mL PI/RNase stain was added to cell pellets. After 30 min at room temperature in the dark, the cell cycle was analyzed with flow cytometre with a 488 nm argon laser.

Cell culture medium of each group was collected respectively and Cells were trypsinized with EDTA-free trypsin. Then washed cells with cold PBS twice and cell counting. 106cells of each group were centrifuged and 400 μL 1 × AnnexinV binding buffer was added to resuspend cells. Afterwards, added  5 μL FITC and 10 μL PI per group for incubation at − 4 °C in the dark for 15 min and 5 min respectively.

Cell migration and invasion assay

The cell migration was measured by wound healing assay. Scratched a line with pipette tip in the middle of each well and washed with PBS 3 times slightly. Then 2 mL of serum-free medium was added to each well and incubation at 37° C for 24 h. The pictures of each group were recorded at 0 h, 6 h, and 12 h under microscopy at 40 magnifications.

The cell invasion was measured by the transwell system (BD, USA). Treated cells were inoculated in the upper chamber with free-FBS medium, and F12 culture medium containing 10% FBS was added to the lower chamber. Additionally, an insert covered with Matrigel was used for invasion measurements. After 24 h, cells migrated to the opposite side of the insert were stained with DAPI and quantified.

Statistical analysis

Data analysis was performed by SPSS 25.0 software. All values are calculated and expressed as mean ± standard deviation (SD). Anaylsis of Variance (ANOVA) and SNK-q test were used to compare between the groups. P-value < 0.05 was considered statistically significant.

Results

S. anginosus growth curve and concentration standard curve were detected and co-culture time and concentration were determined

The growth of S. anginosus is consistent with the general rule which contains four phases, including: 0–4 h lag phase, 4–16 h log phase, 16–24 h stable phase, and 24 h later as the decay phase (Additional file 1: Fig. S1). The stable phase 20 h bacterial solution was selected for experiment because the amount of primary and secondary metabolites of bacteria will reach the maximum in this period. Then, according to the concentration standard curve (Additional file 2: Fig. S2), the relationship between the concentration and the absorbance value can be obtained. The bacterial solution at 20 h was adjusted to the concentration corresponding to the growth curve to ensure the same concentration in each test. Furthermore, the results of CCK-8 assay showed that when a 1:1 relationship between filtrate S and cell culture medium (Additional file 3: Fig. S3) and co-cultured time was 16 h (Additional file 4: Fig. S4), the effect of inhibition to cells was the most obvious. Therefore, this concentration and co-cultured time were used for subsequent experiments.

S. anginosus up-regulated autophagy activity of SCC15

Autophagy is a physiological compensation process to maintain the homeostasis of eukaryotic cells. It can not only exert tumor suppressive effects, but also help tumor cells escape the body's metabolism. A recent study by Chen et al. has supposed that autophagy may inhibited the proliferation of cells [16]. To investigate whether autophagy participates in the action of S. anginosus on SCC15 cells, we first established a model system as the negative group by blocking the autophagy pathway with 3-MA, in which group autophagy activity was inhibited obviously. Vital staining was performed with MDC dyes, which a specific fluorescent marker for autophagic vacuoles showed that compared with SCC15 group, the number of autophagosomes was the highest in SCC15/S group, SCC15/S+3-MA group and SCC15/T group were decreased in turn, and SCC15/3-MA group was the least (Fig. 1a). What’s more, the amount of LC3I protein conversion to LC3II protein has also proved to be well correlated with the degree of autophagy [17]. We found that the mRNA expression of Beclin1 and LC3 were efficiently higher in SCC15/S group than other groups (P < 0.05) and significantly decreased in SCC15/3-MA (P < 0.05) (Fig. 1b). Meanwhile, the expression of autophagy-related protein Beclin1 was significantly enhanced in SCC15/S group and protein LC3 type II increased, type I decreased, showing the transformation from type II to type I. while these two proteins Beclin1 and LC3II were both decreased in SCC15/3-MA group (Fig. 1c; Additional file 5: Fig. S5).

Fig. 1
figure 1

S. anginosus up-regulated autophagy activity of SCC15. a Autophagosomes in cells assessed using MDC staining (× 800 magnification). b The mRNA levels of Beclin1 and LC3 were assessed by qRT-PCR. c The autophagy-associated proteins levels of Beclin1, LC3I and LC3II were assessed using Western blot analysis, and normalized by GAPDH. Data were representative of three independent experiments and shown as mean ± SD, *: P < 0.05, **: P < 0.01 as versus blank control group

Full size image

S. anginosus inhibits the proliferation and promotes apoptosis of SCC15

We evaluated the proliferative activity of SCC15 cells from 0 to 36 h by CCK-8 assay. The results indicated that the SCC15 cells exhibited reduced proliferation after incubation with filtrate S while SCC15/3-MA group revealed slightly increased (P < 0.05). Meanwhile, there was no significant difference between SCC15/T group and SCC15/S+3-MA group compared with the blank control group (Fig. 2a). When flow cytometry was used to analyze cell cycle, the results showed that S. anginosus abundant accumulation of SCC15 cells in the G1 phase (Fig. 2b). In addition, the number of apoptotic cells in SCC15/S group was significantly higher than that in the four control groups (Fig. 2c), and the difference was significant (P < 0.05).

Fig. 2
figure 2

S. anginosus promotes apoptosis of SCC15 and inhibits the proliferation through a cell cycle arrest at the G1/S transition. a CCK-8 assay was performed to test cell proliferation of SCC15 cells. b The cell cycle distributions of SCC15 cells were analyzed with flow cytometry. c Cell apoptosis rate was measured by flow cytometry. Data were representative of three independent experiments and shown as mean ± SD, *: P < 0.05, **: P < 0.01 as versus blank control group

Full size image

S. anginosus was involved in autophagy-mediated inhibition of migration and invasion

The results of wound healing assay showed that the healing area of SCC15/S group was lower than that of all control groups (P < 0.05, Fig. 3a), indicating that the mobility of SCC15/S group was decrease significantly and highly suggesting that S. anginosus was a key factor in the decline of SCC15 cell motility.

Fig. 3
figure 3

S. anginosus was involved in autophagy-mediated inhibition of migration and invasion. a Migratory ability of SCC15 cells was detected by wound healing assay. presence of autophagy in SCC15/S decreased migratory ability compared with control groups (P < 0.05). b Transwell migration assays manifested that up-regulated autophagy decreased numbers of migrated cells. Data were representative of three independent experiments and shown as mean ± SD, *: P < 0.05, **: P < 0.01 as versus blank control group

Full size image

To further evaluate the function of metabolic products of S. anginosus on SCC15 cells invasive ability, transwell chambers coated with matrigel were used. We found that filtrate S of S. anginosus resulted in a significant decrease in invasivity compared with control groups (P < 0.05). However, opposite result was dramatically observed when autophagy was inhibited (P < 0.05, Fig. 3b).

Discussion

The large number of microbiome in the body affects the susceptibility to cancer, partly because its metabolites or co-metabolites have important effects on the function of immune cells. Studies report that 15 to 20 percent of cancer cases are associated with microbial infections [18], but the role of microorganisms in tumor genesis and development is still controversial today. There were some highlighted questions about whether oral microbiome changes are an important risk factor for oral cancer development [19]. According to the results, patients with oral leukoplakia (OLK), a lesion with malignant potential, were more enriched with Fusobacteria compared to normal tissue from the same patients [20]. In addition, the opinion that microbiome changes preceded the malignant transformation process was confirmed, supporting the possible role of microbiome changes in the pathogenesis of disease [9].

Porphyromonas gingivalis is one of the most studied oral microorganisms in vivo and in vitro. Studies have found that continuous stimulation of normal epithelial cells by this kind of bacteria can lead to tumour-like changes in cells [21]. However, the reverse effect was reported in other study [22]. Some researchers have summarized the role of oral microbiota in cancer development. The results suggested that among streptococci, S. anginosus seems to be an especially relevant marker of head, neck, and esophageal cancers and more common in oral squamous cell carcinoma. They also pointed out three mechanisms of oral microbiota in cancer pathogenesis. The first is bacterial stimulation of chronic inflammation. The second is activation of NF-κB and inhibition of cellular apoptosis; And the third is the carcinogens produced by bacteria [23].

S. anginosus, as a human symbiotic bacterium, was first proposed in 1983 that it may be involved in the occurrence and development of oral infectious diseases [14]. In recent years, many relevant studies have claimed that the detection rate of this bacterium in OSCC tissues has increased [24], but its actual effect and mechanism on tumor cells have not been reported. SASAKI et al. isolated and purified a new bioactive antigen SAA (S. anginosus antigen) from S. anginosus supernatant. They found that SAA stimulated macrophages to produce high concentrations of nitric oxide (NO) and various inflammatory factors. NO interacted with O2 or O2- to form reactive nitrogen species (RNS), which leads to a DNA damage response by DNA base oxidation and nitration. In addition, the β-hemolysin of S. anginosus and the streptolysin S (SLS) of Streptococcus pyogenes are homologous series encoded by a similar gene cluster; SLS is a highly toxic cytolysin, which help bacteria to cross the epithelial barrier with a tissue damage and also can against the immune clearance of hosts [25]. Based on the reported toxic effects of metabolites of this bacteria, we selected S. anginosus supernatant of stable period for treatment and retained the metabolites in the supernatant for related experiments.

Autophagy is a physiological compensation process which cell removes damaged proteins and organelles to maintain its homeostasis [26]. Stress reactions such as starvation, hypoxia and microbial infection can stimulate autophagy. Many literatures have stated the relationship between tumor, microorganism and autophagy [27,28,29]. However, it is not clear whether the decrease in autophagy activity observed in malignant cells is mechanically significant or merely incidental to the progression of malignancy. Invasion and metastasis are the critical markers in the development of cancer, and active cell migration plays an essential role in the invasion and metastasis cascade of cancers. Our study confirmed that S. anginosus reduced the proliferation, migration and invasion of SCC15 cells and promoted cell apoptosis; Furthermore, it has been found that Beclin1 located in the cytoplasmic endoplasmic reticulum is involved in the formation of autophagic vesicles and also an important factor in inducing autophagic death of tumor cells. Structurally, Beclin1 has the BH3 region that constitutes the apoptotic bcl-2 protein family, and it is a specific receptor of apoptosis, so it plays an important role in promoting apoptosis [30]. In this study, MDC staining, qPCR and western blot results also confirmed increased autophagy activity and up-regulated expression of Beclin1 during this process, which was consistent with our results of increased apoptosis rate.

Picardo SL et al. suggested that microbial regulation may affect the course of the disease [31]. In patients with advanced cancer treated with immunotherapy, resistance is associated with microbiome abnormalities and antibiotic treatment. There is certainly evidence that the gut flora plays a key role in the response of cancer patients to chemoradiotherapy and immunotherapy. Microbiota transplantation (MT), including fecal microbiota transplantation (FMT) and selective microbiota transplantation (SMT), may improve the effect of anti-cancer treatment and/or reduce the related side effects [32]. Viaud et al. demonstrated that cyclophosphamide causes discontinuity of the intestinal barrier and subsequently promotes selective transfer of specific Gram-positive bacteria to secondary lymphoid organs. These transplanted bacteria can enhance the anti-cancer adaptive immune response of T cells [33].

A new study indicates that the composition of the patient's intestinal flora is an important factor in regulating the host's response to anti-PD-1 / PD-L1 or anti-CTLA-4 immunotherapy [34]. In addition, the view that regulation of the microbiome can be used in cancer treatment was proposed [35]. The study in a mouse model of colonic carcinogenesis showed that oral intake of probiotics containing lactobacilli can reduce IL-17-producing T cells and inhibit proliferation and tumor formation, which may be achieved by changing the gut microbiome. National Institute of Health reconstructed the laboratory mice with natural “wild-type” microbiota, and increased resistance to mutagen and inflammation-induced colorectal tumorigenesis were found [36]. Wang et al. observed that S. anginosus stimulated peripheral blood of OSCC patients and healthy people, and found that CD8 T cells were significantly higher in OSCC patients, proving that Streptococcus-reactive CD8 T cell responses might contribute to antitumor immunity in OSCC patients [37].

Above all, microbiome profoundly affects immune development and carcinogenesis. microbiome-modulating agents are poised to become bona fide anti-cancer strategies: immunotherapy. Immunotherapy derives from the recognition of the synergy between host and microbe. In 1850, several German physicians found that some cancer patients with active infections showed signs of tumor regression. In 1900, Coley test bacterial extracted on patients with bone cancer which was one of the first immunotherapies [38]. For the past three decades, several bacteria-based cancer treatments have emerged, and bacterial vaccines expressing tumor antigens have been shown to be effective in preclinical studies. Bacillus Calmette-Guerin (BCG) was used in the treatment of non-muscular invasive bladder cancer, where directly transmitted live bacteria enter the bladder, causing inflammation and triggering an anti-tumor immune response [39]. Synthetic biology approaches to cancer care hold enormous potential, especially those that make use of bacteria. These methods involve reengineering of bacterial cells for the delivery biomolecules in host reactions. The concept that microorganisms can invade cancer cells to target and disrupt critical cancer pathways has been demonstrated. The next step will be to use robust preclinical models for evaluation.

Oral microflora is composed of many microorganisms, among which there are complex interrelationships. In our study, the outcome of the effect of other microorganisms on the interaction of S. anginosus and the exact clinical role of S. anginosus are not clear. Our experiment is only an initial exploratory experiment. So, the interaction of S. anginosus with more OSCC cell line and normal cells and vivo research should be verified by further experiments.

Conclusions

Our study showed the inhibitory effect of S. anginosus on cancer cells. We believe that the results of such studies, including the present ones, could provide an entry point for future studies of cellular interactions between bacteria and cancer. In addition, future studies should be designed to elucidate the impacts of S. anginosus on the chemotherapeutic responses of oral cancer cells, of which outcomes will have a significant impact on the clinical treatment of oral cancer.

Availability of data and materials

The datasets used during the current study are available from the corresponding author on reasonable request.

Abbreviations

S. anginosus :

Streptococcus anginosus

OSCC:

Oral squamous cell carcinoma

3-MA:

3-Methyladenine

MDC:

Monodansylcadaverine

ANOVA:

Anaylsis of Variance

OLK:

Oral leukoplakia

SAA:

Streptococcus anginosus antigen

NO:

NItric oxide

RNS:

Reactive nitrogen species

SLS:

Streptolysin S

MT:

Microbiota transplantation

FMT:

Fecal microbiota transplantation

SMT:

Selective microbiota transplantation

References

  1. Allavena P, Garlanda C, Borrello MG, Sica A, Mantovani A. Pathways connecting inflammation and cancer. Curr Opin Genet Dev. 2008;18(1):3–10.

    Article  Google Scholar 

  2. Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309–14.

    Article  Google Scholar 

  3. Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol. 2014;12(10):661–72.

    Article  Google Scholar 

  4. Guglielmi G. How gut microbes are joining the fight against cancer. Nature. 2018;557(7706):482–4.

    Article  Google Scholar 

  5. Zitvogel L, Ma Y, Raoult D, Kroemer G, Gajewski TF. The microbiome in cancer immunotherapy: diagnostic tools and therapeutic strategies. Science. 2018;359(6382):1366–70.

    Article  Google Scholar 

  6. Sullivan LB, Gui DY, Vander Heiden MG. Altered metabolite levels in cancer: implications for tumour biology and cancer therapy. Nat Rev Cancer. 2016;16(11):680–93.

    Article  Google Scholar 

  7. Krogh P, Hald B, Holmstrup P. Possible mycological etiology of oral mucosal cancer: catalytic potential of infecting Candida albicans and other yeasts in production of N-nitrosobenzylmethylamine. Carcinogenesis. 1987;8(10):1543–8.

    Article  Google Scholar 

  8. Nagy KN, Sonkodi I, Szöke I, Nagy E, Newman HN. The microflora associated with human oral carcinomas. Oral Oncol. 1998;34(4):304–8.

    Article  Google Scholar 

  9. Schmidt BL, Kuczynski J, Bhattacharya A, Huey B, Corby PM, Queiroz EL, et al. Changes in abundance of oral microbiota associated with oral cancer. PLoS ONE. 2014;9(8):e106297.

    Article  Google Scholar 

  10. Sasaki H, Ishizuka T, Muto M, Nezu M, Nakanishi Y, Inagakl Y, et al. Presence of Streptococcus anginosus DNA in esophageal cancer, dysplasia of esophagus, and gastric cancer. Cancer Res. 1998;58(14):2991–5.

    PubMed  Google Scholar 

  11. Morita E, Narikiyo M, Nishimura E, Yano A, Tanabe C, Sasaki H, Tajika S, Kodama Y, Ohya T, et al. Molecular analysis of age-related changes of Streptococcus anginosus group and Streptococcus mitis in saliva. Oral Microbiol Immunol. 2004;19(6):386–9.

    Article  Google Scholar 

  12. Sasaki M, Yamaura C, Ohara-Nemoto Y, Tajika S, Kodama Y, Ohya T, et al. Streptococcus anginosus infection in oral cancer and its infection route. Oral Dis. 2005;11(3):151–6.

    Article  Google Scholar 

  13. Hamada S, Slade HD. Biology, immunology, and cariogenicity of Streptococcus mutans. Microbiol Rev. 1980;44(2):331–84.

    Article  Google Scholar 

  14. Crawford I, Russell C. Streptococci isolated from the bloodstream and gingival crevice of man. J Med Microbiol. 1983;16(3):263–9.

    Article  Google Scholar 

  15. Tateda M, Shiga K, Saijo S, Michiyo S, Tetsuya H, Junkichi Y, et al. Streptococcus anginosus in head and neck squamous cell carcinoma: implication in carcinogenesis. Int J Mol Med. 2000;6(6):699–703.

    PubMed  Google Scholar 

  16. Chen N, Eritja N, Lock R, Debnath J. Autophagy restricts proliferation driven by oncogenic phosphatidylinositol 3-kinase in three-dimensional culture. Oncogene. 2013;32(20):2543–54.

    Article  Google Scholar 

  17. Mizushima N, Yoshimori T. How to interpret LC3 immunoblotting. Autophagy. 2007;3(6):542–5.

    Article  Google Scholar 

  18. Schwabe RF, Jobin C. The microbiome and cancer. Nat Rev Cancer. 2013;13(11):800–12.

    Article  Google Scholar 

  19. Healy CM, Moran GP. The microbiome and oral cancer: more questions than answers. Oral Oncol. 2019;89:30–3.

    Article  Google Scholar 

  20. Amer A, Galvin S, Healy CM, Moran GP. The microbiome of potentially malignant oral leukoplakia exhibits enrichment for fusobacterium, leptotrichia, campylobacter, and rothia species. Front Microbiol. 2017;8:2391.

    Article  Google Scholar 

  21. Geng F, Liu J, Guo Y, Li C, Wang HY, Zhao HJ, et al. Persistent exposure to porphyromonas gingivalis promotes proliferative and invasion capabilities, and tumorigenic properties of human immortalized oral epithelial cells. Front Cell Infect Microbiol. 2017;7:57.

    Article  Google Scholar 

  22. Cho TJ, Wee SW, Woo VH, Choi JI, Kim SJ, Shin HI, et al. Porphyromonas gingivalis-induced autophagy suppresses cell proliferation through G1 arrest in oral cancer cells. Arch Oral Biol. 2014;59(4):370–8.

    Article  Google Scholar 

  23. Karpiński TM. Role of oral microbiota in cancer development. Microorganisms. 2019;7(1):20.

    Article  Google Scholar 

  24. Sasaki M, Ohara-Nemoto Y, Tajika S, Kobayashi M, Yamaura C, Kimura S. Antigenic characterisation of a novel Streptococcus anginosus antigen that induces nitric oxide synthesis by murine peritoneal exudate cells. J Med Microbiol. 2001;50(11):952–8.

    Article  Google Scholar 

  25. Asam D, Mauerer S, Spellerberg B. Streptolysin S of Streptococcus anginosus exhibits broad-range hemolytic activity. Med Microbiol Immunol. 2015;204(2):227–37.

    Article  Google Scholar 

  26. Yoshimori T. Autophagy: a regulated bulk degradation process inside cells. Biochem Biophys Res Commun. 2004;313(2):453–8.

    Article  Google Scholar 

  27. Cosway B, Lovat P. The role of autophagy in squamous cell carcinoma of the head and neck. Oral Oncol. 2016;54:1–6.

    Article  Google Scholar 

  28. Castrejón-Jiménez NS, Leyva-Paredes K, Hernández-González JC, Luna-Herrera J, García-Pérez BE. The role of autophagy in bacterial infections. Biosci Trends. 2015;9(3):149–59.

    Article  Google Scholar 

  29. Garrett WS. Cancer and the microbiota. Science. 2015;348(6230):80–6.

    Article  Google Scholar 

  30. Weng J, Wang C, Wang Y, Tang HK, Liang JF, Liu XQ, et al. Beclin1 inhibits proliferation, migration and invasion in tongue squamous cell carcinoma cell lines. Oral Oncol. 2014;50(10):983–90.

    Article  Google Scholar 

  31. Picardo SL, Coburn B, Hansen AR. The microbiome and cancer for clinicians. Crit Rev Oncol Hematol. 2019;141:1–12.

    Article  Google Scholar 

  32. Wu X, Zhang T, Chen X, Ji G, Zhang F. Microbiota transplantation: targeting cancer treatment. Cancer Lett. 2019;452:144–51.

    Article  Google Scholar 

  33. Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillere R, Hannani D, et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science. 2013;342(6161):971–6.

    Article  Google Scholar 

  34. Kroemer G, Zitvogel L. Cancer immunotherapy in 2017: the breakthrough of the microbiota. Nat Rev Immunol. 2018;18(2):87–8.

    Article  Google Scholar 

  35. Rong J, Liu S, Hu C, Liu C. Single probiotic supplement suppresses colitis-associated colorectal tumorigenesis by modulating inflammatory development and microbial homeostasis. J Gastroenterol Hepatol. 2019;34(7):1182–92.

    Article  Google Scholar 

  36. Rosshart SP, Vassallo BG, Angeletti D, Hutchinson DS, Morgan AP, Takeda K, et al. Wild mouse gut microbiota promotes host fitness and improves disease resistance. Cell. 2017;171(5):1015-1028.e13.

    Article  Google Scholar 

  37. Wang J, Sun F, Lin X, Li Z, Mao X, Jiang C. Cytotoxic T cell responses to Streptococcus are associated with improved prognosis of oral squamous cell carcinoma. Exp Cell Res. 2018;362(1):203–8.

    Article  Google Scholar 

  38. Mellman I, Coukos G, Dranoff G. Cancer immunotherapy comes of age. Nature. 2011;480:480–9.

    Article  Google Scholar 

  39. Ingersoll MA, Albert ML. From infection to immunotherapy: host immune responses to bacteria at the bladder mucosa. Mucosal Immunol. 2013;6:1041–53.

    Article  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This work was funded by National Natural Science Foundation of China (No. 31371473 and No. 31571508 to Dq.Y, No. 81700958 to L.C.) The National Natural Science Foundation had no role in design of the study, the collection, analysis, and interpretation of data and writing the manuscript. It supported the funding of the study only.

Author information

Authors and Affiliations

  1. College of Stomatology, Chongqing Medical University, Songshi Road No. 426, Yubei District, Chongqing, China

    Yuan Xu, Yuhuan Jia, Liang Chen, Jing Gao & DeQin Yang

  2. Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Songshi Road No. 426, Yubei District, Chongqing, China

    Yuan Xu, Yuhuan Jia, Liang Chen, Jing Gao & DeQin Yang

  3. Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Songshi Road No. 426, Yubei District, Chongqing, China

    Yuan Xu, Yuhuan Jia, Liang Chen, Jing Gao & DeQin Yang

Authors
  1. Yuan Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuhuan Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Liang Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jing Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. DeQin Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

YX designed and conducted the experiment, YHJ、LC and JG performed the literature review and experimental analysis and DQY supervised the work and reviewed the manuscript, and revised the final manuscript as submitted. YX drafted the manuscript. All the authors have read and approved the final manuscript.

Corresponding author

Correspondence to DeQin Yang.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

Growth curve of Streptococcus anginosus. The growth cycle of S.anginosus including: 0–4 h lag phase, 4–16 h log phase, 16–24 h stable phase, and 24 h later as the decay phase. The stable phase 20 h bacterial solution was selected for the next experiments because of the maximum metabolites in this period.

Additional file 2.

Standard curve of Streptococcus anginosus concentration. The relationship between concentration and absorbance value can be obtained according to the formula. And the absorbance value of stable phase 20 h bacterial solution was a standard in each experiment.

Additional file 3.

Determination of the co-culture concentration. A series of concentrations of filtrate S were applied to SCC15, and the results of CCK-8 assay showed that when a 1:1 relationship between filtrate S and cell culture medium, the most significant inhibition was obtained.

Additional file 4.

Determination of the co-culture time. According to the growth curve, the optimal ration of filtrate S and cell culture medium was applied to SCC15, and the cell viability measured at the corresponding time point of the growth curve. Co-culture for 16 hours had the most obvious inhibitory effect on cells.

Additional file 5.

 Original blot images.The autophagy-associated proteins levels of Beclin1, LC3I and LC3II were assessed using Western blot analysis, and normalized by GAPDH.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, Y., Jia, Y., Chen, L. et al. Effect of Streptococcus anginosus on biological response of tongue squamous cell carcinoma cells. BMC Oral Health 21, 141 (2021). https://doi.org/10.1186/s12903-021-01505-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12903-021-01505-3

Keywords

BMC Oral Health

ISSN: 1472-6831

Contact us